Irreversible blindness in juvenile systemic lupus erythematosus

被引:9
作者
Almeida, R. T. [1 ]
Aikawa, N. E. [1 ,2 ]
Sallum, A. M. E. [1 ]
Jesus, A. A. [1 ]
Sa, L. C. F. [3 ]
Silva, C. A. [1 ,2 ]
机构
[1] Univ Sao Paulo, Fac Med, Childrens Hosp, Pediat Rheumatol Unit,Hosp Clin, Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Div Rheumatol, Hosp Clin, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med, Childrens Hosp, Ophthalmol Unit,Hosp Clin, Sao Paulo, Brazil
关键词
Retinal vasculitis; uveitis; blindness; juvenile systemic lupus erythematosus; SEVERE VASOOCCLUSIVE RETINOPATHY; DISEASE;
D O I
10.1177/0961203310378412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blindness caused by severe vasculitis or uveitis is rare in juvenile systemic lupus erythematosus (JSLE) patients. In a 27-year period, 5367 patients were followed at our Paediatric Rheumatology Division and 263 (4.9%) patients had JSLE (American College of Rheumatology criteria). Of note, two (0.8%) of them had irreversible blindness. One of them presented with cutaneous vasculitis and malar rash, associated with pain and redness in both eyes, impairment of visual acuity due to iridocyclitis and severe retinal vasculitis with haemorrhage. Another patient had peripheral polyneuropathy of the four limbs and received immunosuppressive drugs. Three weeks later, she developed diffuse herpes zoster associated with acute blindness due to bilateral retinal necrotizing vasculitis compatible with varicella zoster virus ocular infection. Despite prompt treatment, both patients suffered rapid irreversible blindness. In conclusion, irreversible blindness due to retinal vasculitis and/or uveitis is a rare and severe lupus manifestation, particularly associated with disease activity and viral infection. Lupus (2011) 20, 95-97.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 11 条
[1]  
Al-Mayouf SM, 2003, SAUDI MED J, V24, P964
[2]   Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment [J].
Au, A ;
O'Day, J .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (01) :87-100
[3]  
Bandyopadhyay Sanjay K, 2006, J Indian Med Assoc, V104, P526
[4]  
Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P155, DOI 10.1080/08820530500232027
[5]  
Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P237
[6]   Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus [J].
Faco, M. M. M. ;
Leone, C. ;
Campos, L. M. A. ;
Febronio, M. V. ;
Marques, H. H. S. ;
Silva, C. A. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (07) :993-1002
[7]  
Gladman DD, 2002, J RHEUMATOL, V29, P288
[8]   Severe vaso-occlusive retinopathy as the primary manifestation in a patient with systemic lupus erythematosus [J].
Ho, Tsung-Yu ;
Chung, Yu-Mei ;
Lee, An-Fei ;
Tsai, Chang-Youh .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2008, 71 (07) :377-380
[9]   Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J].
Hochberg, MC .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1725-1725
[10]  
Kotaniemi K, 2001, J RHEUMATOL, V28, P309